Lukasz S. Borowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lukasz S. Borowski has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Roman J. Szczesny
Institute of Biochemistry and Biophysics, Polish Academy of Sciences
22 shared publications - Andrzej Dziembowski
International Institute of Molecular and Cell Biology in Warsaw
7 shared publications Piotr P. Stepien
Institute of Biochemistry and Biophysics Polish Academy of Sciences, Laboratory of RNA Biology and Functional Genomics, Pawinskiego 5A, 02-106, Warsaw, Poland
5 shared publications- Anna V. Kotrys
Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, USA
4 shared publications - Dominik Cysewski
Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland
4 shared publications - Maciej Szewczyk
University of Gdansk Gdansk Poland
4 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (35)
Loss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity
Chronic interferon (IFN) activation is a hallmark of autoimmune diseases such as systemic lupus erythematosus and Sjögren’s disease (SjD), where epithelial cells are key contributors. Although viral and retroelement triggers have been proposed as triggers, direct evidence in patient tissues is limited, and endogenous mechanisms of epithelial IFN dysregulation remain unclear. Mitochondrial double-stranded RNA (mt-dsRNA) is a potent type I IFN (IFN-I) inducer, but its regulation in epithelial cells is poorly understood. We identify a mechanism in which the RNA methyltransferase METTL3 stabilizes REXO2 mRNA in primary salivary gland epithelial cells through N6 -methyladenosine (m 6 A) modification. REXO2 encodes a mitochondrial exonuclease that controls mt-dsRNA. METTL3 inhibition reduces REXO2, causing mt-dsRNA accumulation and IFN-I signaling amplification and inflammation. Single-cell and bulk transcriptomic analyses, together with immunofluorescence of salivary gland tissues from SjD patients and controls, reveal reduced REXO2 expression and elevated IFN-I signatures in SjD. Rexo2 is likewise downregulated in epithelial cells of a spontaneous SjD mouse model. REXO2 loss amplifies IFN-I responses and inflammation across several epithelial contexts, while methyl donors restore REXO2 and dampen IFN activation, highlighting a targetable regulatory checkpoint in IFN-driven autoimmune diseases, alongside potential parallel stress pathways.
- 24 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (35)
Open AccessLoss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity
Chronic interferon (IFN) activation is a hallmark of autoimmune diseases such as systemic lupus erythematosus and Sjögren’s disease (SjD), where epithelial cells are key contributors. Although viral and retroelement triggers have been proposed as triggers, direct evidence in patient tissues is limited, and endogenous mechanisms of epithelial IFN dysregulation remain unclear. Mitochondrial double-stranded RNA (mt-dsRNA) is a potent type I IFN (IFN-I) inducer, but its regulation in epithelial cells is poorly understood. We identify a mechanism in which the RNA methyltransferase METTL3 stabilizes REXO2 mRNA in primary salivary gland epithelial cells through N6 -methyladenosine (m 6 A) modification. REXO2 encodes a mitochondrial exonuclease that controls mt-dsRNA. METTL3 inhibition reduces REXO2, causing mt-dsRNA accumulation and IFN-I signaling amplification and inflammation. Single-cell and bulk transcriptomic analyses, together with immunofluorescence of salivary gland tissues from SjD patients and controls, reveal reduced REXO2 expression and elevated IFN-I signatures in SjD. Rexo2 is likewise downregulated in epithelial cells of a spontaneous SjD mouse model. REXO2 loss amplifies IFN-I responses and inflammation across several epithelial contexts, while methyl donors restore REXO2 and dampen IFN activation, highlighting a targetable regulatory checkpoint in IFN-driven autoimmune diseases, alongside potential parallel stress pathways.
- Open Access
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9984
TTC33 forms a complex with WDR61 and PHF5A to recruit factors relevant to genomic integrity
The functions of many human proteins remain unknown, highlighting major gaps in our understanding of cellular biology. TTC33 is an evolutionarily conserved tetratricopeptide repeat (TPR) protein expressed across human tissues, whose molecular role is not defined. Here we identify the TTC33 partners using comparative label-free mass spectrometry. The TTC33-associated network (TAN) comprises WDR61, CCDC97, UNG1/2, PP2A-B55α, PHF5A, and components of the SF3B U2 spliceosomal complex. Using a combination of biochemical assays, structural modeling and molecular dynamics we show that TTC33 directly recruits WDR61 and PHF5A to assemble into a trimeric core complex (TANC), which then forms distinct interactions with either UNG1/2 or SF3B–CCDC97. Somatic TTC33 mutations at key TANC interface residues reduce complex stability and weaken the interaction network. We further show that WDR61 stabilizes TTC33 by protecting it from proteolytic degradation. Loss of network components induces genomic instability and activates DNA damage markers, including γH2AX and p53 phosphorylation.
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9984
Open AccessTTC33 forms a complex with WDR61 and PHF5A to recruit factors relevant to genomic integrity
The functions of many human proteins remain unknown, highlighting major gaps in our understanding of cellular biology. TTC33 is an evolutionarily conserved tetratricopeptide repeat (TPR) protein expressed across human tissues, whose molecular role is not defined. Here we identify the TTC33 partners using comparative label-free mass spectrometry. The TTC33-associated network (TAN) comprises WDR61, CCDC97, UNG1/2, PP2A-B55α, PHF5A, and components of the SF3B U2 spliceosomal complex. Using a combination of biochemical assays, structural modeling and molecular dynamics we show that TTC33 directly recruits WDR61 and PHF5A to assemble into a trimeric core complex (TANC), which then forms distinct interactions with either UNG1/2 or SF3B–CCDC97. Somatic TTC33 mutations at key TANC interface residues reduce complex stability and weaken the interaction network. We further show that WDR61 stabilizes TTC33 by protecting it from proteolytic degradation. Loss of network components induces genomic instability and activates DNA damage markers, including γH2AX and p53 phosphorylation.
- Open Access
- 11 August 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (15)
Genome-wide in vivo and ex vivo mapping of R-loops using engineered N-terminal hybrid-binding domain of RNase H3 (enDR3)
R-loops are nucleic acid structures composed of an RNA/DNA hybrid and a displaced single-stranded DNA that form during transcription. Their defective processing has been implicated in genome instability, which is associated with severe human diseases. Despite their biological significance, the mechanisms regulating R-loops remain incompletely understood, underscoring the need for improved tools to accurately map R-loops across the genome. Here, we propose enDR3, a novel tool designed to capture and sequence RNA/DNA hybrids for precise R-loop localization. enDR3 is an engineered tandem fusion of the N-terminal hybrid-binding domain from bacterial RNase H3, modified with specific amino acid substitutions to enhance its affinity and specificity for RNA/DNA hybrids. This engineered protein provides an important alternative to the widely used S9.6 antibody-based immunoprecipitation methods. We successfully applied enDR3 for genome-wide R-loop profiling using DNA/RNA immunoprecipitation with complementary DNA conversion and chromatin immunoprecipitation techniques, followed by sequencing. Our results confirm that enDR3 enables robust R-loop detection in both in vitro and in vivo, providing a versatile tool for advancing R-loop biology.
- 11 August 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (15)
Open AccessGenome-wide in vivo and ex vivo mapping of R-loops using engineered N-terminal hybrid-binding domain of RNase H3 (enDR3)
R-loops are nucleic acid structures composed of an RNA/DNA hybrid and a displaced single-stranded DNA that form during transcription. Their defective processing has been implicated in genome instability, which is associated with severe human diseases. Despite their biological significance, the mechanisms regulating R-loops remain incompletely understood, underscoring the need for improved tools to accurately map R-loops across the genome. Here, we propose enDR3, a novel tool designed to capture and sequence RNA/DNA hybrids for precise R-loop localization. enDR3 is an engineered tandem fusion of the N-terminal hybrid-binding domain from bacterial RNase H3, modified with specific amino acid substitutions to enhance its affinity and specificity for RNA/DNA hybrids. This engineered protein provides an important alternative to the widely used S9.6 antibody-based immunoprecipitation methods. We successfully applied enDR3 for genome-wide R-loop profiling using DNA/RNA immunoprecipitation with complementary DNA conversion and chromatin immunoprecipitation techniques, followed by sequencing. Our results confirm that enDR3 enables robust R-loop detection in both in vitro and in vivo, providing a versatile tool for advancing R-loop biology.
- Open Access
- 22 July 2025
- Published by Springer Nature in Research Square
Coupling translation termination to RNA surveillance: roles of release factors in quality control and RNA degradation pathways in mammalian mitochondria
Accurate protein synthesis depends on the proper recognition of stop codons by release factors (RFs). The human mitochondrial genome deviates from the standard genetic code by using not only the canonical stop codons UAG and UAA but also two non-canonical stop codons, AGA and AGG. Consequently, human mitochondria employ two release factors—mtRF1a and mtRF1—that recognize canonical and non-canonical stop codons, respectively. Surprisingly, mtRF1 is conserved across vertebrates, despite the absence of non-canonical stop codons in many species. Here, we investigate the function of mtRF1 in Mus musculus, whose mitochondrial open reading frames (mt-ORFs) lack non-canonical stop codons. Using a combination of biochemical approaches and mitoribosome profiling, we demonstrate that mtRF1 retains functional activity as a non-canonical RF, mediating an alternative release mechanism for COX1 via stop codon readthrough. Similarly, in human mitochondria, AGG stop codon readthrough enables ND6 release by mtRF1a in the absence of mtRF1. Our data reveal that mitoribosome stop codon readthrough is a conserved mechanism that compensates for the loss of RFs. While this mechanism facilitates access to alternative stop codons, it is also associated with RNA degradation. A targeted siRNA screen shows that components of the mitochondrial degradosome—including PNPase and SUV3—as well as the mitochondrial poly(A) polymerase MTPAP, participate in this decay pathway. Together, our study provides new insights into mitochondrial translation termination and RNA quality control, revealing stop codon readthrough as a rescue mechanism that enables the completion of mitochondrial protein synthesis when standard termination fails.
- 22 July 2025
- Published by Springer Nature in Research Square
Open AccessCoupling translation termination to RNA surveillance: roles of release factors in quality control and RNA degradation pathways in mammalian mitochondria
Accurate protein synthesis depends on the proper recognition of stop codons by release factors (RFs). The human mitochondrial genome deviates from the standard genetic code by using not only the canonical stop codons UAG and UAA but also two non-canonical stop codons, AGA and AGG. Consequently, human mitochondria employ two release factors—mtRF1a and mtRF1—that recognize canonical and non-canonical stop codons, respectively. Surprisingly, mtRF1 is conserved across vertebrates, despite the absence of non-canonical stop codons in many species. Here, we investigate the function of mtRF1 in Mus musculus, whose mitochondrial open reading frames (mt-ORFs) lack non-canonical stop codons. Using a combination of biochemical approaches and mitoribosome profiling, we demonstrate that mtRF1 retains functional activity as a non-canonical RF, mediating an alternative release mechanism for COX1 via stop codon readthrough. Similarly, in human mitochondria, AGG stop codon readthrough enables ND6 release by mtRF1a in the absence of mtRF1. Our data reveal that mitoribosome stop codon readthrough is a conserved mechanism that compensates for the loss of RFs. While this mechanism facilitates access to alternative stop codons, it is also associated with RNA degradation. A targeted siRNA screen shows that components of the mitochondrial degradosome—including PNPase and SUV3—as well as the mitochondrial poly(A) polymerase MTPAP, participate in this decay pathway. Together, our study provides new insights into mitochondrial translation termination and RNA quality control, revealing stop codon readthrough as a rescue mechanism that enables the completion of mitochondrial protein synthesis when standard termination fails.
- Open Access
- 30 June 2025
- Published by Izmir Akademi Dernegi in Journal of Metaverse
- Vol. 5 (1) , 1-24
Valuation and Volatility of Virtual Properties in Metaverse: Exploring New Market Opportunities and Speculative Dynamics Based on Decentraland
Existing reality has been repeatedly subjected to multifaceted and multidimensional analyses. However, alongside it, a virtual reality exists, populated with virtual art, objects in games, cyber-pets, and virtual properties, collectively worth billions of real dollars. This virtual reality is associated with the concept of the 'metaverse' (a term derived from 'meta' and 'universe'), signifying a space that facilitates life in a virtual world. This space has a quantifiable value and is traded on specially designed platforms. The study focuses on the largest of these platforms, Decentraland, where users can purchase virtual properties using a cryptocurrency called MANA. Based on an analysis of 207 property transactions, the study examines whether these properties can be appraised using typical approaches applicable to “real” properties. It explores the relationship between spatial attributes, property price, and price volatility over time, calculating correlation coefficients for this purpose. Additionally, the study investigates the number of property sales, including multiple sales, and the proportion of properties with ITEMs on them, determining the correlation coefficients between price and parcel attributes. This study is the first to accomplish what researchers in the real estate market have long been doing. The results distinctly show that the virtual real estate market is governed by different factors compared to the traditional market, with property price and location remaining as two crucial aspects in the decision-making process for purchasing a property.
- 30 June 2025
- Published by Izmir Akademi Dernegi in Journal of Metaverse
- Vol. 5 (1) , 1-24
Open AccessValuation and Volatility of Virtual Properties in Metaverse: Exploring New Market Opportunities and Speculative Dynamics Based on Decentraland
Existing reality has been repeatedly subjected to multifaceted and multidimensional analyses. However, alongside it, a virtual reality exists, populated with virtual art, objects in games, cyber-pets, and virtual properties, collectively worth billions of real dollars. This virtual reality is associated with the concept of the 'metaverse' (a term derived from 'meta' and 'universe'), signifying a space that facilitates life in a virtual world. This space has a quantifiable value and is traded on specially designed platforms. The study focuses on the largest of these platforms, Decentraland, where users can purchase virtual properties using a cryptocurrency called MANA. Based on an analysis of 207 property transactions, the study examines whether these properties can be appraised using typical approaches applicable to “real” properties. It explores the relationship between spatial attributes, property price, and price volatility over time, calculating correlation coefficients for this purpose. Additionally, the study investigates the number of property sales, including multiple sales, and the proportion of properties with ITEMs on them, determining the correlation coefficients between price and parcel attributes. This study is the first to accomplish what researchers in the real estate market have long been doing. The results distinctly show that the virtual real estate market is governed by different factors compared to the traditional market, with property price and location remaining as two crucial aspects in the decision-making process for purchasing a property.
- Open Access
The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation
The transporter associated with antigen processing (TAP) is a key player in the MHC class I-restricted antigen presentation and an attractive target for immune evasion by viruses. Bovine herpesvirus 1 (BoHV-1) impairs TAP-dependent antigenic peptide transport through a two-pronged mechanism in which binding of the UL49.5 gene product to TAP both inhibits peptide transport and promotes its proteasomal degradation. How UL49.5 promotes TAP degradation is unknown. Here, we use high-content siRNA and genome-wide CRISPR-Cas9 screening to identify CLR2 KLHDC3 as the E3 ligase responsible for UL49.5-triggered TAP disposal in human cells. We propose that the C-terminus of UL49.5 mimics a C-end rule degron that recruits the E3 to TAP and engages the CRL2 E3 in ER-associated degradation. SIGNIFICANCE: Herpesviruses are masters of immune evasion. Most often, they hijack host cellular pathways to modulate the antiviral immune response. Varicellovirus UL49.5 orthologs have evolved as inhibitors of the transporter associated with antigen processing (TAP) and, this way, major modulators of the MHC class I-restricted antigen presentation. This study identifies the long-sought molecular mechanism exploited by bovine herpesvirus 1-encoded UL49.5 to trigger proteasomal degradation of TAP. Our findings demonstrate that the viral protein hijacks host cell CRL2-ubiquitin conjugation and ER-associated degradation pathways to promote TAP degradation. These findings advance the understanding of how herpesviruses can manipulate the cellular machinery.
Open AccessThe herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation
The transporter associated with antigen processing (TAP) is a key player in the MHC class I-restricted antigen presentation and an attractive target for immune evasion by viruses. Bovine herpesvirus 1 (BoHV-1) impairs TAP-dependent antigenic peptide transport through a two-pronged mechanism in which binding of the UL49.5 gene product to TAP both inhibits peptide transport and promotes its proteasomal degradation. How UL49.5 promotes TAP degradation is unknown. Here, we use high-content siRNA and genome-wide CRISPR-Cas9 screening to identify CLR2 KLHDC3 as the E3 ligase responsible for UL49.5-triggered TAP disposal in human cells. We propose that the C-terminus of UL49.5 mimics a C-end rule degron that recruits the E3 to TAP and engages the CRL2 E3 in ER-associated degradation. SIGNIFICANCE: Herpesviruses are masters of immune evasion. Most often, they hijack host cellular pathways to modulate the antiviral immune response. Varicellovirus UL49.5 orthologs have evolved as inhibitors of the transporter associated with antigen processing (TAP) and, this way, major modulators of the MHC class I-restricted antigen presentation. This study identifies the long-sought molecular mechanism exploited by bovine herpesvirus 1-encoded UL49.5 to trigger proteasomal degradation of TAP. Our findings demonstrate that the viral protein hijacks host cell CRL2-ubiquitin conjugation and ER-associated degradation pathways to promote TAP degradation. These findings advance the understanding of how herpesviruses can manipulate the cellular machinery.
Mitochondrial RNA, a new trigger of the innate immune system
Mitochondria play a pivotal role in numerous cellular processes. One of them is regulation of the innate immune pathway. In this instance, mitochondria function in two different aspects of regulatory mechanisms. First, mitochondria are part of the antiviral signaling cascade that is triggered in the cytoplasm and transmitted to effector proteins through mitochondria‐localized proteins. Second, mitochondria can become an endogenous source of innate immune stimuli. Under some pathophysiological conditions, mitochondria release to the cytoplasm immunogenic factors, such as mitochondrial nucleic acids. Here, we focus on immunogenic mitochondrial double‐stranded RNA (mt‐dsRNA) and its origin and metabolism. We discuss factors that are responsible for regulating mt‐dsRNA and its escape from mitochondria, emphasizing the contribution of polynucleotide phosphorylase (PNPase, PNPT1). Finally, we review current knowledge of the role of PNPase in human health and disease.This article is categorized under: RNA in Disease and Development > RNA in Disease
Mitochondrial RNA, a new trigger of the innate immune system
Mitochondria play a pivotal role in numerous cellular processes. One of them is regulation of the innate immune pathway. In this instance, mitochondria function in two different aspects of regulatory mechanisms. First, mitochondria are part of the antiviral signaling cascade that is triggered in the cytoplasm and transmitted to effector proteins through mitochondria‐localized proteins. Second, mitochondria can become an endogenous source of innate immune stimuli. Under some pathophysiological conditions, mitochondria release to the cytoplasm immunogenic factors, such as mitochondrial nucleic acids. Here, we focus on immunogenic mitochondrial double‐stranded RNA (mt‐dsRNA) and its origin and metabolism. We discuss factors that are responsible for regulating mt‐dsRNA and its escape from mitochondria, emphasizing the contribution of polynucleotide phosphorylase (PNPase, PNPT1). Finally, we review current knowledge of the role of PNPase in human health and disease.This article is categorized under: RNA in Disease and Development > RNA in Disease
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (18) , 167125
DNA Repair Protein APE1 Degrades Dysfunctional Abasic mRNA in Mitochondria Affecting Oxidative Phosphorylation
- 1 September 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (18) , 167125
Open AccessDNA Repair Protein APE1 Degrades Dysfunctional Abasic mRNA in Mitochondria Affecting Oxidative Phosphorylation
- Open Access
- 1 January 2021
- Published by Wiley in The FEBS Journal
- Vol. 288 (2) , 434-436
Loading messenger RNAs onto ribosomes in human mitochondria: lessons learned from a bacterial toxin
Mitochondria are peculiar organelles because their function depends on genetic information that is present in two genomes: nuclear and mitochondrial. The expression of mitochondrially encoded information requires dedicated machinery. Many efforts have been made to identify this machinery and describe its relevant mechanisms. Recently, Bruniet al. reported a cellular model that they established to investigate the pathway for loading messenger RNAs onto ribosomes in human mitochondria. Their study revealed a role for monosome formation in the stability of mitochondrial mRNAs. Comment on:
- 1 January 2021
- Published by Wiley in The FEBS Journal
- Vol. 288 (2) , 434-436
Open AccessLoading messenger RNAs onto ribosomes in human mitochondria: lessons learned from a bacterial toxin
Mitochondria are peculiar organelles because their function depends on genetic information that is present in two genomes: nuclear and mitochondrial. The expression of mitochondrially encoded information requires dedicated machinery. Many efforts have been made to identify this machinery and describe its relevant mechanisms. Recently, Bruniet al. reported a cellular model that they established to investigate the pathway for loading messenger RNAs onto ribosomes in human mitochondria. Their study revealed a role for monosome formation in the stability of mitochondrial mRNAs. Comment on:
- 24 November 2020
- Published by Springer Nature
- Vol. 2192, 133-146
High-Throughput Measurement of Mitochondrial RNA Turnover in Human Cultured Cells
RNA turnover is an essential part of the gene expression pathway, and there are several experimental approaches for its determination. High-throughput measurement of global RNA turnover rates can provide valuable information about conditions or proteins that impact gene expression. Here, we present a protocol for mitochondrial RNA turnover analysis which involves metabolic labeling of RNA coupled with quantitative high-throughput fluorescent microscopy. This approach gives an excellent opportunity to discover new factors involved in mitochondrial gene regulation when combined with loss-of-function screening strategy.
- 24 November 2020
- Published by Springer Nature
- Vol. 2192, 133-146
High-Throughput Measurement of Mitochondrial RNA Turnover in Human Cultured Cells
RNA turnover is an essential part of the gene expression pathway, and there are several experimental approaches for its determination. High-throughput measurement of global RNA turnover rates can provide valuable information about conditions or proteins that impact gene expression. Here, we present a protocol for mitochondrial RNA turnover analysis which involves metabolic labeling of RNA coupled with quantitative high-throughput fluorescent microscopy. This approach gives an excellent opportunity to discover new factors involved in mitochondrial gene regulation when combined with loss-of-function screening strategy.